Inovio Pharmaceuticals, Inc.-Product Pipeline Review-2015

Inovio Pharmaceuticals, Inc.-Product Pipeline Review-2015

  • Products Id :- GMDHC07246CDB
  • |
  • Pages: 71
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Inovio Pharmaceuticals, Inc.-Product Pipeline Review-2015


Global Markets Direct's, 'Inovio Pharmaceuticals, Inc.-Product Pipeline Review-2015', provides an overview of the Inovio Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Inovio Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Inovio Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Inovio Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Inovio Pharmaceuticals, Inc.'s pipeline products

Reasons To Buy

Evaluate Inovio Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Inovio Pharmaceuticals, Inc. in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Inovio Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Inovio Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Inovio Pharmaceuticals, Inc.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Inovio Pharmaceuticals, Inc. and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 6

List of Figures 6

Inovio Pharmaceuticals, Inc. Snapshot 7

Inovio Pharmaceuticals, Inc. Overview 7

Key Information 7

Key Facts 7

Inovio Pharmaceuticals, Inc.-Research and Development Overview 8

Key Therapeutic Areas 8

Inovio Pharmaceuticals, Inc.-Pipeline Review 11

Pipeline Products by Stage of Development 11

Pipeline Products-Monotherapy 12

Pipeline Products-Out-Licensed Products 13

Out-Licensed Products/Combination Treatment Modalities 14

Inovio Pharmaceuticals, Inc.-Pipeline Products Glance 15

Inovio Pharmaceuticals, Inc.-Clinical Stage Pipeline Products 15

Phase II Products/Combination Treatment Modalities 15

Phase I Products/Combination Treatment Modalities 16

Inovio Pharmaceuticals, Inc.-Early Stage Pipeline Products 17

Preclinical Products/Combination Treatment Modalities 17

Inovio Pharmaceuticals, Inc.-Drug Profiles 18

VGX-3100 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

INO-3112 19

Product Description 19

Mechanism of Action 19

R&D Progress 19

INO-8000 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

FVH-1 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

INO-1400 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

INO-3106 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

INO-3401 24

Product Description 24

Mechanism of Action 24

R&D Progress 24

INO-3510 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

INO-3605 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

INO-3609 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

INO-4212 28

Product Description 28

Mechanism of Action 28

R&D Progress 28


Product Description 29

Mechanism of Action 29

R&D Progress 29


Product Description 31

Mechanism of Action 31

R&D Progress 31


Product Description 32

Mechanism of Action 32

R&D Progress 32

VRC-01 33

Product Description 33

Mechanism of Action 33

R&D Progress 33

chikungunya vaccine 36

Product Description 36

Mechanism of Action 36

R&D Progress 36

Clostridium difficile vaccine 37

Product Description 37

Mechanism of Action 37

R&D Progress 37

dengue [serotypes 1,2,3,4] (tetravalent) vaccine 38

Product Description 38

Mechanism of Action 38

R&D Progress 38

Gene Therapy for Ebola Virus Infections 39

Product Description 39

Mechanism of Action 39

R&D Progress 39

influenza [H7N9] vaccine 40

Product Description 40

Mechanism of Action 40

R&D Progress 40

influenza [strain A/H3N2] vaccine 41

Product Description 41

Mechanism of Action 41

R&D Progress 41

INO-4500 42

Product Description 42

Mechanism of Action 42

R&D Progress 42

INO-5150 43

Product Description 43

Mechanism of Action 43

R&D Progress 43

INO-7103 44

Product Description 44

Mechanism of Action 44

R&D Progress 44

INO-7105 45

Product Description 45

Mechanism of Action 45

R&D Progress 45

MAV-12 46

Product Description 46

Mechanism of Action 46

R&D Progress 46

Monoclonal Antibodies for Cancer and Immunology 47

Product Description 47

Mechanism of Action 47

R&D Progress 47

RSQ-15 48

Product Description 48

Mechanism of Action 48

R&D Progress 48

Vaccine for Cancer 49

Product Description 49

Mechanism of Action 49

R&D Progress 49

Vaccines for Neurological Disorders 50

Product Description 50

Mechanism of Action 50

R&D Progress 50

Inovio Pharmaceuticals, Inc.-Pipeline Analysis 51

Inovio Pharmaceuticals, Inc.-Pipeline Products by Target 51

Inovio Pharmaceuticals, Inc.-Pipeline Products by Route of Administration 53

Inovio Pharmaceuticals, Inc.-Pipeline Products by Molecule Type 54

Inovio Pharmaceuticals, Inc.-Pipeline Products by Mechanism of Action 55

Inovio Pharmaceuticals, Inc.-Recent Pipeline Updates 56

Inovio Pharmaceuticals, Inc.-Dormant Projects 65

Inovio Pharmaceuticals, Inc.-Discontinued Pipeline Products 66

Discontinued Pipeline Product Profiles 66

mifepristone 66

VGX-410C 66

Inovio Pharmaceuticals, Inc.-Company Statement 67

Inovio Pharmaceuticals, Inc.-Locations And Subsidiaries 69

Head Office 69

Other Locations & Subsidiaries 69

Appendix 70

Methodology 70

Coverage 70

Secondary Research 70

Primary Research 70

Expert Panel Validation 70

Contact Us 70

Disclaimer 71

List of Tables

Inovio Pharmaceuticals, Inc., Key Information 7

Inovio Pharmaceuticals, Inc., Key Facts 7

Inovio Pharmaceuticals, Inc.-Pipeline by Indication, 2015 9

Inovio Pharmaceuticals, Inc.-Pipeline by Stage of Development, 2015 11

Inovio Pharmaceuticals, Inc.-Monotherapy Products in Pipeline, 2015 12

Inovio Pharmaceuticals, Inc.-Out-Licensed Products in Pipeline, 2015 13

Inovio Pharmaceuticals, Inc.-Out-Licensed Products/ Combination Treatment Modalities, 2015 14

Inovio Pharmaceuticals, Inc.-Phase II, 2015 15

Inovio Pharmaceuticals, Inc.-Phase I, 2015 16

Inovio Pharmaceuticals, Inc.-Preclinical, 2015 17

Inovio Pharmaceuticals, Inc.-Pipeline by Target, 2015 52

Inovio Pharmaceuticals, Inc.-Pipeline by Route of Administration, 2015 53

Inovio Pharmaceuticals, Inc.-Pipeline by Molecule Type, 2015 54

Inovio Pharmaceuticals, Inc.-Pipeline Products by Mechanism of Action, 2015 55

Inovio Pharmaceuticals, Inc.-Recent Pipeline Updates, 2015 56

Inovio Pharmaceuticals, Inc.-Dormant Developmental Projects,2015 65

Inovio Pharmaceuticals, Inc.-Discontinued Pipeline Products, 2015 66

Inovio Pharmaceuticals, Inc., Subsidiaries 69

List of Figures

Inovio Pharmaceuticals, Inc.-Pipeline by Top 10 Indication, 2015 9

Inovio Pharmaceuticals, Inc.-Pipeline by Stage of Development, 2015 11

Inovio Pharmaceuticals, Inc.-Monotherapy Products in Pipeline, 2015 12

Inovio Pharmaceuticals, Inc.-Pipeline by Top 10 Target, 2015 51

Inovio Pharmaceuticals, Inc.-Pipeline by Top 10 Route of Administration, 2015 53

Inovio Pharmaceuticals, Inc.-Pipeline by Top 10 Molecule Type, 2015 54

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@]

Current R&D Portfolio of Inovio Pharmaceuticals, Inc.; Inovio Pharmaceuticals, Inc. - Key Therapeutics; Inovio Pharmaceuticals, Inc. - Pipeline Overview and Promising Molecules; Inovio Pharmaceuticals, Inc. - News; Inovio Pharmaceuticals, Inc. - Latest Updates; Inovio Pharmaceuticals, Inc. - Pipeline; Inovio Pharmaceuticals, Inc. - Discontinued/Dormant Projects

select a license

Single User License
USD 1500 INR 101625
Site License
USD 3000 INR 203250
Corporate User License
USD 4500 INR 304875



Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@]